Spero Therapeutics (SPRO) FCF Margin Growth (5y) (2021 - 2026)
Spero Therapeutics (SPRO) FCF Margin Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Spero Therapeutics | 70.14 Mn | 19.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 636,088.00 |
| Dec 31, 2025 | 92,444.00 |
| Sep 30, 2025 | 85,368.00 |
| Jun 30, 2025 | 131,775.00 |
| Mar 31, 2025 | -3.20 Mn |
| Dec 31, 2024 | -4.25 Mn |
| Sep 30, 2024 | 2.53 Mn |
| Jun 30, 2024 | 1.80 Mn |
| Mar 31, 2024 | 438,402.00 |
| Dec 31, 2023 | 100,073.00 |
| Sep 30, 2023 | 90,047.00 |
| Jun 30, 2023 | 118,280.00 |
| Dec 31, 2022 | 154,805.00 |
| Sep 30, 2022 | 167,286.00 |
| Jun 30, 2022 | 99,441.00 |
| Mar 31, 2022 | -644,132.00 |
| Dec 31, 2021 | -1.43 Mn |